Fast ventricular tachycardias in patients with implantable cardioverter-defibrillators: Efficacy and safety of antitachycardia pacing - A prospective and randomized study
[EN]In this prospective, multicenter, randomized study of 137 patients with ICDs, the programming of antitachycardia pacing therapy (ATP) consisting of a burst of 5 pulses at 84% of the tachycardia cycle length (CL) reduced by 84% the incidence of shocks to treat fast ventricular tachycardias (FVT),...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2005 |
| País: | España |
| Institución: | Universidad de Salamanca (USAL) |
| Repositorio: | GREDOS. Repositorio Institucional de la Universidad de Salamanca |
| OAI Identifier: | oai:gredos.usal.es:10366/160973 |
| Acceso en línea: | http://hdl.handle.net/10366/160973 |
| Access Level: | acceso abierto |
| Palabra clave: | Antitachycardia pacing Implantable cardioverter-defibrillator Aged Prospective Studies Treatment Outcome Humans Defibrillators Middle Aged Tachycardia desfibriladores resultado del tratamiento humanos anciano mediana edad taquicardia estudios prospectivos |
| Sumario: | [EN]In this prospective, multicenter, randomized study of 137 patients with ICDs, the programming of antitachycardia pacing therapy (ATP) consisting of a burst of 5 pulses at 84% of the tachycardia cycle length (CL) reduced by 84% the incidence of shocks to treat fast ventricular tachycardias (FVT), defined by a CL between 240-310 ms. The strategy based on ATP programming was associated with a reduction in episode duration (9.3 s ± 8.4 vs 14.8 ± 4.6 s; p<0.05) and the incidence of syncope/near-syncope due to FVT (3.7% vs. 54%; p<0.001). Beta- blocker therapy was associated with an increased ATP efficacy. |
|---|